What Researchers Did
Researchers conducted a systematic review and pooled analysis of four US Department of Defense clinical trials (254 participants) plus three additional published studies (135 participants) testing HBOT for persistent post-concussive symptoms and PTSD after mild traumatic brain injury.
What They Found
Pooled analysis showed a trend favoring HBOT for post-concussive symptoms and PTSD that did not reach statistical significance, but demonstrated a statistically significant improvement in verbal memory (p = 0.01). A dose-response pattern was observed, with higher oxygen pressure associated with greater benefit.
What This Means for Canadian Patients
Mild TBI and PTSD are significant concerns for Canadian veterans and contact sport athletes. This pooled analysis suggests HBOT may improve memory and thinking after concussion, particularly at higher pressures, supporting calls for a Canadian clinical trial targeting this population.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
Pooled analyses can mask heterogeneity between studies; the populations were primarily US military personnel, which may not represent civilian Canadian patients with concussion.